

第1页 / 共15页

第2页 / 共15页

第3页 / 共15页
试读已结束,还剩12页,您可下载完整版后进行离线阅读
2023HKSR共识建议:痛风的管理此内容为付费资源,请付费后查看
赞助会员一年免费赞助会员三年免费
付费资源
© 版权声明
1、当您下载文档后,您只拥有了使用权限,并不意味着购买了版权,文档只能用于自身学习参考,不得用于其他商业用途(如 [转卖]进行直接盈利或[编辑后售卖]进行间接盈利)。
2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,请自行鉴别。
3、如文档内容存在违规,或者侵犯商业秘密、侵犯著作权等,请“联系客服处理”。
4、内容来源于网络,仅限用于学习和研究目的,版权争议与本站无关。您必须在下载后的24个小时之内,从您的电脑中彻底删除上述内容。如有侵权请与我们联系处理。
THE END
Clinical Rheumatologyhttp5/doi.org/10.1007/s10067-023-06578-9REVIEW ARTICLEThe Hong Kong Society of Rheumatology consensusrecommendations for the management of goutRonald ML Yip'.Tommy T Cheung2.Ho So3.Julia PS Chan2.Carmen TK Ho.Helen HL Tsang.Carrel KL Yu5.Priscilla CH Wong3.for the Hong Kong Society of RheumatologyReceived:2 December 2022/Revised:9 February 2023/Accepted:12 March 2023©The Author(s)2023AbstractGout is one of the most common noncommunicable diseases in Hong Kong.Although effective treatment options are read-ily available,the management of gout in Hong Kong remains suboptimal.Like other countries,the treatment goal in HongKong usually focuses on relieving symptoms of gout but not treating the serum urate level to target.As a result,patientswith gout continue to suffer from the debilitating arthritis,as well as the renal,metabolic,and cardiovascular complicationsassociated with gout.The Hong Kong Society of Rheumatology spearheaded the development of these consensus recom-mendations through a Delphi exercise that involved rheumatologists,primary care physicians,and other specialists in HongKong.Recommendations on acute gout management,gout prophylaxis,treatment of hyperuricemia and its precautions,co-administration of non-gout medications with urate-lowering therapy,and lifestyle advice have been included.This paperserves as a reference guide to all healthcare providers who see patients who are at risk and are known to have this chronicbut treatable condition.Keywords Consensus.Gout.Hong Kong Society of Rheumatology.Hyperuricemia.RecommendationsIntroduction[2].Population aging has contributed significantly to theincreased incidence and prevalence of gout in Hong Kong.The global incidence and prevalence of gout has substan-Over the past 20 years,the number of Hong Kong peopletially increased over the past decade [1],and this is noaged 65 years or above increased from 12.5%to 16.1%.Inexception in Hong Kong.A local population-based studyaddition,modifiable risk factors for gout and hyperuricemia,reported an increase in the crude incidence rate of gout fromsuch as regular alcohol consumption,greater meat intake,113.05/100,000 person-years in2006to211.62/100,000and obesity,have been increasing.As a result,the Hongperson-years in 2016 [2].Similarly,the crude prevalenceKong government has included gout,alcohol drinking,andof gout has risen from 1.56%in 2006 to 2.92%in 2016obesity among the target non-communicable diseases in itscampaign programs for primary prevention [3].However,the management of gout in Hong Kong is yet to be improved.☒Ronald ML Yipronald.yip@tungwah.org.hkThe treatment goal usually focuses on relieving symp-toms of arthritis but not treating the underlying hyperurice-Tung Wah Group of Hospitals Integrated Diagnosticmia.Despite the availability and demonstrated efficacy ofand Medical Centre.Kwong Wah Hospital.25.Waterloourate-lowering therapy (ULT)in reducing serum uric acidRoad,Kowloon,Hong Kong(SUA)levels,only 25.55%